KITLG and neoplasm: To examine whether Erk1/2 signaling is required for PKD2/3 induced -SCF, CCL5, and CCL11 expression in tumor cells, we first analyzed the interaction of endogenous PKD2 or PKD3 with Erk1/2 in prostate cancer cells.